These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23102604)

  • 1. Scar imaging using multislice computed tomography versus metabolic imaging by F-18 FDG positron emission tomography: a pilot study.
    Dwivedi G; Al-Shehri H; deKemp RA; Ali I; Alghamdi AA; Klein R; Scullion A; Ruddy TD; Beanlands RS; Chow BJ
    Int J Cardiol; 2013 Sep; 168(2):739-45. PubMed ID: 23102604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of contrast-enhanced MRI with (18)F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease.
    Wu YW; Tadamura E; Yamamuro M; Kanao S; Marui A; Tanabara K; Komeda M; Togashi K
    J Nucl Med; 2007 Jul; 48(7):1096-103. PubMed ID: 17607039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of LVEF assessed by 2D echocardiography, gated blood pool SPECT, 99mTc tetrofosmin gated SPECT, and 18F-FDG gated PET with ERNV in patients with CAD and severe LV dysfunction.
    Raja S; Mittal BR; Santhosh S; Bhattacharya A; Rohit MK
    Nucl Med Commun; 2014 Nov; 35(11):1156-61. PubMed ID: 25144559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase analysis by gated F-18 FDG PET/CT for left ventricular dyssynchrony assessment: a comparison with gated Tc-99m sestamibi SPECT.
    Wang L; Wei HX; Yang MF; Guo J; Wang JF; Fang W; Wang YT
    Ann Nucl Med; 2013 May; 27(4):325-34. PubMed ID: 23371445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging--comparison of the late enhancement technique with positronemission tomography].
    Hunold P; Brandt-Mainz K; Freudenberg L; Vogt FM; Neumann T; Knipp S; Barkhausen J
    Rofo; 2002 Jul; 174(7):867-73. PubMed ID: 12101477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET for detecting myocardial viability: validation of 3D data acquisition.
    Brogsitter C; Grüning T; Weise R; Wielepp P; Lindner O; Körfer R; Burchert W
    J Nucl Med; 2005 Jan; 46(1):19-24. PubMed ID: 15632028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gated fluorine 18 fluorodeoxyglucose positron emission tomography: determination of global and regional left ventricular function and myocardial tissue characterization.
    Saab G; Dekemp RA; Ukkonen H; Ruddy TD; Germano G; Beanlands RS
    J Nucl Cardiol; 2003; 10(3):297-303. PubMed ID: 12794629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function.
    Beanlands RS; Ruddy TD; deKemp RA; Iwanochko RM; Coates G; Freeman M; Nahmias C; Hendry P; Burns RJ; Lamy A; Mickleborough L; Kostuk W; Fallen E; Nichol G;
    J Am Coll Cardiol; 2002 Nov; 40(10):1735-43. PubMed ID: 12446055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
    Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
    J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial viability in chronic ischemic heart disease: comparison of delayed-enhancement magnetic resonance imaging with 99mTc-sestamibi and 18F-fluorodeoxyglucose single-photon emission computed tomography.
    Liu Q; Zhao S; Yan C; Lu M; Jiang S; Zhang Y; Li S; Liu Y; Yang M; He Z
    Nucl Med Commun; 2009 Aug; 30(8):610-6. PubMed ID: 19491715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of left ventricular volumes, ejection fraction and mass. Comparison of model-based analysis of ECG-gated (⁹⁹m)Tc-SPECT and ¹⁸F-FDG-PET.
    Khorsand A; Gyöngyösi M; Sochor H; Maurer G; Karanikas G; Dudczak R; Schuster E; Porenta G; Graf S
    Nuklearmedizin; 2011; 50(1):9-14. PubMed ID: 21165540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/MRI early after myocardial infarction: evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake.
    Rischpler C; Langwieser N; Souvatzoglou M; Batrice A; van Marwick S; Snajberk J; Ibrahim T; Laugwitz KL; Nekolla SG; Schwaiger M
    Eur Heart J Cardiovasc Imaging; 2015 Jun; 16(6):661-9. PubMed ID: 25680385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of inflamed aortic plaque in conventional fluorodeoxyglucose-positron emission tomography myocardial viability studies.
    Liu Y; Ghosh N; Dwivedi G; Chow BJ; deKemp RA; DaSilva J; Guo A; Garrard L; Beanlands RS; Ruddy TD
    Can J Cardiol; 2013 Sep; 29(9):1069-75. PubMed ID: 23664168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of
    Moody JB; Hiller KM; Lee BC; Poitrasson-Rivière A; Corbett JR; Weinberg RL; Murthy VL; Ficaro EP
    J Nucl Cardiol; 2019 Apr; 26(2):374-386. PubMed ID: 30809755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial.
    Abraham A; Nichol G; Williams KA; Guo A; deKemp RA; Garrard L; Davies RA; Duchesne L; Haddad H; Chow B; DaSilva J; Beanlands RS;
    J Nucl Med; 2010 Apr; 51(4):567-74. PubMed ID: 20237039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of PET/CT fusion imaging for three-dimensional myocardial scar and left ventricular anatomy during ventricular tachycardia ablation.
    Tian J; Smith MF; Chinnadurai P; Dilsizian V; Turgeman A; Abbo A; Gajera K; Xu C; Plotnick D; Peters R; Saba M; Shorofsky S; Dickfeld T
    J Cardiovasc Electrophysiol; 2009 Jun; 20(6):567-604. PubMed ID: 19207761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of optimum periods between onset of suspected acute myocarditis and ¹⁸F-fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory left ventricular myocardium.
    Ozawa K; Funabashi N; Daimon M; Takaoka H; Takano H; Uehara M; Kobayashi Y
    Int J Cardiol; 2013 Nov; 169(3):196-200. PubMed ID: 24075573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].
    Schneider CA; Voth E; Theissen P; Wienhard K; Wagner R; Baer FM; Sechtem U; Schicha H
    Z Kardiol; 1994 Feb; 83(2):124-31. PubMed ID: 8165842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of multidetector CT with F-18-FDG-PET and SPECT in the assessment of myocardial viability in patients with myocardial infarction: a preliminary study.
    Lee IH; Choe YH; Lee KH; Jeon ES; Choi JH
    Eur J Radiol; 2009 Dec; 72(3):401-5. PubMed ID: 18849129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.